ANCO’s ASCO23 Highlights will summarize the major research and treatment advancements presented at this year’s ASCO23 Meeting. The program will focus on breast, gastrointestinal, genitourinary, gynecologic, hematologic malignancies, lung cancers, and sarcoma, as well as a plenary session on Equity: Every Patient. Every Day. Everywhere, in addition to a panel on equity. The faculty will place these developments in context as to their immediate clinical utility. 

Location 

For those attendees who are interested in attending in person, the program will be hosted at the Claremont Hotel & Spa, A Fairmont Hotel, 41 Tunnel Rd, Berkeley, CA 94705. For our attendees who prefer to attend from the comfort of their home, we will be live streaming the event and you may register for this option. 

Registration is Complimentary for Physicians and the Cancer Care Community.  Register here: https://cvent.me/Xr4Lez

Industry Registration

At ANCO we strive to foster meaningful connections and facilitate valuable interactions among participants at our events. To ensure a fair distribution of attendance and provide an opportunity for various stakeholders to participate and engage with the cancer care community at large, industry registration for the event is intentionally limited to a maximum of three representatives per company, from companies who are not exhibiting at the event, with a maximum of 20 companies.

Supporters & Exhibitors 

Support for ANCO’s ASCO23 Highlights is  in part from ANCO’s Sustaining Level Corporate Members AbbVie, AstraZeneca, BeiGene, Bristol-Meyers Squibb Oncology, Gilead Sciences, Inc., Grail, GSK Oncology, Incyte, Jazz Pharmaceuticals, Inc.
Kite, A Gilead Company,  Loxo @ Lilly, Merck & Co., Inc., Mirati Therapeutics, MorphoSys US Inc, Pfizer Oncology, PharmaEssentia USA Corporation, Sanofi – Hematology & Oncology, Stemline, A Menarini Group Company, Taiho Oncology Inc., and  Takeda Oncology, and the following exhibitors: Astellas Oncology, Biotheranostics, Boehringer Ingelheim, Deciphera, Exact Sciences, Exelixis, Inc., GE Healthcare, Karyopharm, Puma Biotechnology, Regeneron and Seagen. Our exhibit hall is fully committed at this time.